Catalyst Wire Dossier Catalyst Wire Dossier

[13C] Pyruvate MRI imaging agent

13C-labeled pyruvate · Memorial Sloan Kettering Cancer Center
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [13C] Pyruvate MRI imaging agent, covering 2026-02-20 to 2026-02-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of [13C]Pyruvate as an Imaging Agent for Magnetic Resonance Imaging in Healthy Volunteers [Phase 1]

See pricing